Figure 2From: Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa CD4% changes of HIV-1 infected children in the MRC Fajara cohort in response to ART. Median CD4% and median increase in CD4% from baseline among HIV-1 infected children <5 years of age at ART start.Back to article page